Tillkännagivande • Aug 04
TAKE LIMITED to Report Q1, 2027 Results on Aug 11, 2026 TAKE LIMITED announced that they will report Q1, 2027 results on Aug 11, 2026 Valuation Update With 7 Day Price Move • Jul 16
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₹20.05, the stock trades at a trailing P/E ratio of 69.7x. Average trailing P/E is 23x in the Healthcare Services industry in Asia. Total returns to shareholders of 13% over the past three years. Valuation Update With 7 Day Price Move • Jul 02
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to ₹22.83, the stock trades at a trailing P/E ratio of 79.4x. Average trailing P/E is 23x in the Healthcare Services industry in Asia. Total returns to shareholders of 35% over the past three years. Tillkännagivande • May 16
TAKE Solutions Limited to Report Q4, 2026 Results on May 20, 2026 TAKE Solutions Limited announced that they will report Q4, 2026 results on May 20, 2026 Board Change • Mar 01
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. Additional Independent Non-Executive Director Pushpa Joshi is the most experienced director on the board, commencing their role in 2025. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. New Risk • Feb 16
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -₹225m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹225m free cash flow). Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (₹7.14b market cap, or US$78.7m). Tillkännagivande • Feb 11
TAKE Solutions Limited Approves Appointment of Mr. Vilas Munis as Additional Non-Executive Non-Independent Director, Effective February 11, 2026 TAKE Solutions Limited announced that the Board of Directors of the Company at its meeting held on 11 February, 2026, have approved the Appointment of Mr. Vilas Munis as Additional Non-Executive Non-Independent Director of the Company, Date of appointment 11 February 2026. Mr. Vilas Munis is a graduate and has professional experience in administration and management. Mr. Vilas Munis is not related to any Directors of the Company. He is not debarred from holding the office pursuant to any SEBI order or any other authority. Tillkännagivande • Feb 06
TAKE Solutions Limited to Report Q3, 2026 Results on Feb 14, 2026 TAKE Solutions Limited announced that they will report Q3, 2026 results at 9:08 AM, Indian Standard Time on Feb 14, 2026 Board Change • Jan 13
High number of new and inexperienced directors There are 3 new directors who have joined the board in the last 3 years. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. Additional Independent Non-Executive Director Pushpa Joshi is the most experienced director on the board, commencing their role in 2025. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Tillkännagivande • Oct 22
TAKE Solutions Limited to Report Q2, 2026 Results on Oct 27, 2025 TAKE Solutions Limited announced that they will report Q2, 2026 results on Oct 27, 2025 Valuation Update With 7 Day Price Move • Oct 03
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₹12.66, the stock trades at a trailing P/E ratio of 70.9x. Average trailing P/E is 26x in the Healthcare Services industry in Asia. Total loss to shareholders of 50% over the past three years. Tillkännagivande • Sep 08
TAKE Solutions Limited, Annual General Meeting, Sep 30, 2025 TAKE Solutions Limited, Annual General Meeting, Sep 30, 2025, at 16:30 Indian Standard Time. Tillkännagivande • Aug 21
Aakanksha Management Consultancy & Holdings Private Limited acquired 19% stake in TAKE Solutions Limited (NSEI:TAKE) from TAKE Solutions Pte. Limited. Aakanksha Management Consultancy & Holdings Private Limited acquired 19% stake in TAKE Solutions Limited (NSEI:TAKE) from TAKE Solutions Pte. Limited on August 18, 2025. Aakanksha Management Consultancy & Holdings acquired 28,107,460 shares.
Aakanksha Management Consultancy & Holdings Private Limited completed the acquisition of 19% stake in TAKE Solutions Limited (NSEI:TAKE) from TAKE Solutions Pte. Limited on August 18, 2025. Valuation Update With 7 Day Price Move • Aug 20
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹11.03, the stock trades at a trailing P/E ratio of 61.8x. Average trailing P/E is 34x in the Healthcare Services industry in Asia. Total loss to shareholders of 57% over the past three years. Board Change • Jul 26
High number of new directors There are 6 new directors who have joined the board in the last 3 years. Independent Non-Executive Director Peeyush Sethia was the last director to join the board, commencing their role in 2025. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Tillkännagivande • Jul 25
Asia Global Trading (Chennai) Pvt Ltd acquired 19% stake in TAKE Solutions Limited (NSEI:TAKE) from TAKE Solutions Pte. Limited. Asia Global Trading (Chennai) Pvt Ltd acquired 19% stake in TAKE Solutions Limited (NSEI:TAKE) from TAKE Solutions Pte. Limited on July 22, 2025.
Asia Global Trading (Chennai) Pvt Ltd completed the acquisition of 19% stake in TAKE Solutions Limited (NSEI:TAKE) from TAKE Solutions Pte. Limited on July 22, 2025. As a result of this transaction, TAKE Solutions Pte. Limited stake in TAKE Solutions Limited reduced to 33.90% from 52.90%. Tillkännagivande • Jul 02
TAKE Solutions Limited to Report Q1, 2026 Results on Jul 07, 2025 TAKE Solutions Limited announced that they will report Q1, 2026 results at 12:08 PM, Indian Standard Time on Jul 07, 2025 New Risk • Jun 02
New minor risk - Revenue size The company makes less than US$5m in revenue. Total revenue: ₹102m (US$1.2m) This is considered a minor risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (97% accrual ratio). Minor Risks Revenue is less than US$5m (₹102m revenue, or US$1.2m). Market cap is less than US$100m (₹1.27b market cap, or US$14.9m). Tillkännagivande • May 23
TAKE Solutions Limited to Report Q4, 2025 Results on May 30, 2025 TAKE Solutions Limited announced that they will report Q4, 2025 results on May 30, 2025 Tillkännagivande • Apr 02
Take Solutions Limited Announces Resignation of Kiran Sharma as Non-Executive Independent Director TAKE Solutions Limited announced that Ms. Kiran Sharma has resigned from the position of Non-Executive Independent Director of the Company with effect from 2nd April 2025 due to pre-occupations. New Risk • Apr 02
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.7% average weekly change). Negative equity (-₹142m). Minor Risk Market cap is less than US$100m (₹1.08b market cap, or US$12.6m). Tillkännagivande • Mar 08
Take Solutions Limited Announces Resignation of Chella Gowrishankar as Non-Executive Non-Independent Director TAKE Solutions Limited informed that Mr. Chella Gowrishankar (DIN: 00269690) has resigned from the position of Non-Executive Non-Independent Director of the Company with effect from 07th March 2025 due to preoccupation with other professional commitments. New Risk • Feb 21
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Negative equity (-₹142m). Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Market cap is less than US$100m (₹1.64b market cap, or US$19.0m). Tillkännagivande • Feb 06
TAKE Solutions Limited to Report Q3, 2025 Results on Feb 12, 2025 TAKE Solutions Limited announced that they will report Q3, 2025 results on Feb 12, 2025 Reported Earnings • Jan 23
First half 2025 earnings released: ₹0.31 loss per share (vs ₹0.47 loss in 1H 2024) First half 2025 results: ₹0.31 loss per share (improved from ₹0.47 loss in 1H 2024). Net loss: ₹44.6m (loss narrowed 35% from 1H 2024). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings. Tillkännagivande • Dec 26
TAKE Solutions Limited to Report Q2, 2025 Results on Jan 22, 2025 TAKE Solutions Limited announced that they will report Q2, 2025 results on Jan 22, 2025 Tillkännagivande • Oct 05
TAKE Solutions Limited Announces Resignation of Shobana as Executive Director TAKE Solutions Limited informed that Ms. Shobana has resigned from the position of Executive Director of the Company with effect from 05 October, 2024. Resignation due to professional commitments and personal reasons. Reported Earnings • Jul 24
Full year 2024 earnings released: ₹8.18 loss per share (vs ₹3.21 loss in FY 2023) Full year 2024 results: ₹8.18 loss per share (further deteriorated from ₹3.21 loss in FY 2023). Revenue: ₹656.1m (down 65% from FY 2023). Net loss: ₹1.20b (loss widened 155% from FY 2023). Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings. New Risk • Jun 04
New major risk - Negative shareholders equity The company has negative equity. Total equity: -₹89m This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Negative equity (-₹89m). Earnings have declined by 9.7% per year over the past 5 years. Minor Risks Market cap is less than US$100m (₹2.80b market cap, or US$33.5m). Tillkännagivande • May 31
TAKE Solutions Limited, Annual General Meeting, Aug 14, 2024 TAKE Solutions Limited, Annual General Meeting, Aug 14, 2024. Tillkännagivande • May 22
TAKE Solutions Limited to Report Q4, 2024 Results on May 30, 2024 TAKE Solutions Limited announced that they will report Q4, 2024 results on May 30, 2024 New Risk • Feb 16
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 0.9x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.9x net interest cover). Earnings have declined by 18% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Market cap is less than US$100m (₹4.37b market cap, or US$52.7m). Reported Earnings • Feb 14
Third quarter 2024 earnings released: ₹0.15 loss per share (vs ₹0.70 loss in 3Q 2023) Third quarter 2024 results: ₹0.15 loss per share (improved from ₹0.70 loss in 3Q 2023). Revenue: ₹179.4m (down 67% from 3Q 2023). Net loss: ₹21.4m (loss narrowed 79% from 3Q 2023). Over the last 3 years on average, earnings per share has increased by 92% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings. Tillkännagivande • Jan 29
TAKE Solutions Limited to Report Q3, 2024 Results on Feb 13, 2024 TAKE Solutions Limited announced that they will report Q3, 2024 results on Feb 13, 2024 New Risk • Jan 18
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 28% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.5% average weekly change). Market cap is less than US$100m (₹4.14b market cap, or US$49.8m). Reported Earnings • Nov 10
Second quarter 2024 earnings released: ₹0.11 loss per share (vs ₹1.97 loss in 2Q 2023) Second quarter 2024 results: ₹0.11 loss per share (improved from ₹1.97 loss in 2Q 2023). Revenue: ₹182.4m (down 59% from 2Q 2023). Net loss: ₹15.5m (loss narrowed 95% from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 86% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings. Tillkännagivande • Nov 03
TAKE Solutions Limited to Report Q2, 2024 Results on Nov 08, 2023 TAKE Solutions Limited announced that they will report Q2, 2024 results on Nov 08, 2023 Tillkännagivande • Aug 07
TAKE Solutions Limited to Report Q1, 2024 Results on Aug 14, 2023 TAKE Solutions Limited announced that they will report Q1, 2024 results on Aug 14, 2023 Reported Earnings • Jul 22
Full year 2023 earnings released: ₹3.21 loss per share (vs ₹5.66 loss in FY 2022) Full year 2023 results: ₹3.21 loss per share (improved from ₹5.66 loss in FY 2022). Revenue: ₹1.89b (down 71% from FY 2022). Net loss: ₹468.6m (loss narrowed 43% from FY 2022). Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings. Tillkännagivande • Jul 18
TAKE Solutions Limited, Annual General Meeting, Aug 14, 2023 TAKE Solutions Limited, Annual General Meeting, Aug 14, 2023, at 11:00 Indian Standard Time. Agenda: To consider the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2023, together with the Reports of the Board of Directors and Auditors thereon; to consider the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2023, together with the Report of the Auditors thereon; and to appoint Mr. Chella Gowrishankar who retires by rotation in terms of Section 152(6) of the Companies Act, 2013 at this Annual General Meeting and being eligible, seeks re-appointment. Reported Earnings • May 31
Full year 2023 earnings released: ₹3.21 loss per share (vs ₹6.08 loss in FY 2022) Full year 2023 results: ₹3.21 loss per share (improved from ₹6.08 loss in FY 2022). Revenue: ₹1.98b (down 70% from FY 2022). Net loss: ₹469.5m (loss narrowed 47% from FY 2022). Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has fallen by 33% per year, which means it is significantly lagging earnings. Tillkännagivande • May 20
TAKE Solutions Limited to Report Q4, 2023 Results on May 29, 2023 TAKE Solutions Limited announced that they will report Q4, 2023 results at 4:00 PM, Indian Standard Time on May 29, 2023 Board Change • Mar 26
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Additional Non-Executive Independent Director Kiran Sharma was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Feb 15
Third quarter 2023 earnings released: ₹0.70 loss per share (vs ₹2.86 loss in 3Q 2022) Third quarter 2023 results: ₹0.70 loss per share (improved from ₹2.86 loss in 3Q 2022). Revenue: ₹549.7m (down 74% from 3Q 2022). Net loss: ₹101.7m (loss narrowed 76% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 41% per year, which means it is significantly lagging earnings. Tillkännagivande • Feb 07
TAKE Solutions Limited to Report Q3, 2023 Results on Feb 14, 2023 TAKE Solutions Limited announced that they will report Q3, 2023 results on Feb 14, 2023 Reported Earnings • Dec 09
Second quarter 2023 earnings released: ₹1.97 loss per share (vs ₹0.61 loss in 2Q 2022) Second quarter 2023 results: ₹1.97 loss per share (further deteriorated from ₹0.61 loss in 2Q 2022). Revenue: ₹489.1m (down 75% from 2Q 2022). Net loss: ₹288.8m (loss widened 225% from 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has fallen by 36% per year, which means it is performing significantly worse than earnings. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Additional Independent Director Ramesh Gopal was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 21
First quarter 2023 earnings released: ₹0.37 loss per share (vs ₹0.22 loss in 1Q 2022) First quarter 2023 results: ₹0.37 loss per share (further deteriorated from ₹0.22 loss in 1Q 2022). Revenue: ₹579.1m (down 72% from 1Q 2022). Net loss: ₹54.4m (loss widened 70% from 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 40% per year whereas the company’s share price has fallen by 39% per year. Buying Opportunity • Aug 05
Now 23% undervalued after recent price drop Over the last 90 days, the stock is down 3.2%. The fair value is estimated to be ₹35.02, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 43% over the last 3 years. Meanwhile, the company became loss making. Reported Earnings • May 29
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: ₹6.08 loss per share (up from ₹31.01 loss in FY 2021). Revenue: ₹6.72b (down 13% from FY 2021). Net loss: ₹888.8m (loss narrowed 80% from FY 2021). Revenue missed analyst estimates by 13%. Earnings per share (EPS) were also behind analyst expectations. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has only fallen by 47% per year, which means it has not declined as severely as earnings. Buying Opportunity • May 05
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 33%. The fair value is estimated to be ₹34.68, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 37% over the last 3 years. Meanwhile, the company became loss making. Board Change • Apr 27
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 8 experienced directors. 3 highly experienced directors. Non-Executive Independent Director Srini Srinivasan was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Mar 29
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 8 experienced directors. 3 highly experienced directors. Non-Executive Independent Director Srini Srinivasan was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Buying Opportunity • Mar 23
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 33%. The fair value is estimated to be ₹38.43, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 37% per annum over the last 3 years. The company became loss making over the last 3 years. Buying Opportunity • Feb 23
Now 23% undervalued after recent price drop Over the last 90 days, the stock is down 32%. The fair value is estimated to be ₹39.22, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 37% per annum over the last 3 years. The company became loss making over the last 3 years. Reported Earnings • Feb 10
Third quarter 2022 earnings: EPS and revenues miss analyst expectations Third quarter 2022 results: ₹2.86 loss per share (down from ₹1.75 loss in 3Q 2021). Revenue: ₹2.07b (down 4.2% from 3Q 2021). Net loss: ₹418.2m (loss widened 63% from 3Q 2021). Revenue missed analyst estimates by 13%. Earnings per share (EPS) were also behind analyst expectations. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 49 percentage points per year, which is a significant difference in performance. Reported Earnings • Jul 23
Full year 2021 earnings released: ₹31.01 loss per share (vs ₹0.84 loss in FY 2020) The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2021 results: Revenue: ₹7.74b (down 65% from FY 2020). Net loss: ₹4.53b (loss widened ₹4.41b from FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance. Reported Earnings • Jun 27
Full year 2021 earnings released: ₹31.01 loss per share (vs ₹0.84 loss in FY 2020) The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2021 results: Revenue: ₹7.74b (down 65% from FY 2020). Net loss: ₹4.53b (loss widened ₹4.41b from FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance. Reported Earnings • Feb 14
Third quarter 2021 earnings released: ₹1.75 loss per share (vs ₹3.45 profit in 3Q 2020) The company reported a poor third quarter result with weaker earnings, revenues and control over costs. Third quarter 2021 results: Revenue: ₹2.26b (down 65% from 3Q 2020). Net loss: ₹256.5m (down 151% from profit in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 99% per year but the company’s share price has only fallen by 30% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Jan 01
New 90-day high: ₹57.40 The company is up 25% from its price of ₹45.80 on 01 October 2020. The Indian market is up 20% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Healthcare Services industry, which is also up 25% over the same period. Is New 90 Day High Low • Dec 16
New 90-day high: ₹49.60 The company is up 3.0% from its price of ₹48.05 on 17 September 2020. The Indian market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is up 20% over the same period. Reported Earnings • Nov 17
Second quarter 2021 earnings released: ₹16.67 loss per share The company reported a poor second quarter result with weaker earnings, revenues and control over expenses. Second quarter 2021 results: Revenue: ₹1.71b (down 72% from 2Q 2020). Net loss: ₹1.19b (down 337% from profit in 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 78% per year but the company’s share price has only fallen by 37% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Nov 14
New 90-day low: ₹39.95 The company is down 15% from its price of ₹47.25 on 14 August 2020. The Indian market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is up 12% over the same period. Is New 90 Day High Low • Oct 29
New 90-day low: ₹41.65 The company is down 2.0% from its price of ₹42.45 on 31 July 2020. The Indian market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is up 6.0% over the same period. 
